“Three medications and my blood pressure was still 158/96. My cardiologist added a fourth drug. I could not tolerate it. That is when I started looking for something different — something that worked with my body, not just piled more chemistry onto it.”
Robert J., a 61-year-old retired firefighter from Atlanta, Georgia, shares his experience with investigational leech therapy as a complementary approach to pharmacological hypertension management.
Background: Treatment-Resistant Hypertension
Robert was diagnosed with hypertension at age 52, initially managed with lifestyle modification. By age 57, he required lisinopril + amlodipine. By age 59, hydrochlorothiazide was added (triple therapy). Ambulatory blood pressure monitoring confirmed treatment-resistant hypertension (TRH) — BP >140/90 despite 3+ optimized agents of different classes. Secondary hypertension workup was negative. His cardiologist recommended spironolactone as a fourth agent, which Robert could not tolerate due to gynecomastia.
“I did everything they asked — lost 30 pounds, cut salt, exercised, took my medications. My blood pressure was still above target on three drugs. At that point it is not a lifestyle problem anymore. Something else is going on.”
The Biological Rationale
Robert researched the vasodilatory compounds in leech salivary gland secretion — particularly histamine-binding proteins, decorsin (a GPIIb/IIIa inhibitor affecting platelet-vascular interactions), and eglin-class anti-inflammatory proteins acting on arterial wall inflammation. While neurological applications remain investigational, the vascular pharmacology of leech SGS provided a mechanistic basis for consultation.
“I am not a doctor, but I spent hours reading the research. The idea that something could address vascular inflammation and platelet activity simultaneously — while my medications only hit blood pressure through single mechanisms — was compelling.”
The Leech Therapy Experience
Under cardiologist co-management, Robert underwent 8 leech therapy sessions over 4 months, supervised by an ASH practitioner. Leeches were applied to posterior cervical and lumbar regions. Blood pressure was monitored at each session and daily at home. No changes to existing medications were made during the trial period.
“My cardiologist asked me at every follow-up: are you still doing the leech therapy? She was skeptical but rigorous. She tracked my BP alongside her own interventions. By month 3, she told me my ambulatory readings were the best she had seen in 4 years.”
Blood Pressure Response
Baseline (ambulatory): 152/94 mmHg. Month 2: 144/90. Month 3: 138/88. Month 4: 136/86. A reduction of 16/8 mmHg from baseline — clinically meaningful but within expected range for lifestyle + pharmacological optimization. Unable to attribute improvement solely to leech therapy vs. continued lifestyle improvements.
“I cannot prove the leeches are responsible. Neither can my cardiologist. But my BP is the best it has been in years, I avoided a fourth medication, and I feel better overall. For me, that is enough to continue.”
Key Outcomes
Medical Perspective
Treating Physician
Dr. James Carter, MD
Cardiology, Hypertension
“Robert's case reflects the challenges of assessing adjunctive therapies in complex cardiovascular management. The 16/8 mmHg reduction is clinically meaningful, but multiple confounders (continued lifestyle modification, seasonal variation, regression to mean) prevent attribution to leech therapy alone. The vascular pharmacology rationale is scientifically legitimate but unvalidated in controlled trials for hypertension. I support Robert's decision to continue but am clear with him: this is investigational, not evidence-based practice.”
Medical Disclaimer
Individual results vary. These stories represent personal experiences and are not guarantees of outcome. Leech therapy requires proper medical supervision. Consult a qualified healthcare provider before starting any treatment.